The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02643251. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1%, to Clonidine Hydrochloride Gel Comparator in the Management of Painful Diabetic Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will include three (3) phases: Screening Phase, Treatment Phase, and Follow-up Phase. Subjects who qualify to participate will apply study drug to their feet three times daily and will record their daily pain scores using an interactive voice response system (IVRS) during the Treatment Phase for 12 weeks. Approximately 100 adult subjects will be randomized to receive Clonidine Gel or Clonidine Gel Comparator.
Study identification
- NCT ID
- NCT02643251
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 138 participants
Conditions and interventions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Type not available)
- Primary completion
- Nov 2016 (Actual)
- Completion
- Nov 2016 (Actual)
- Last update posted
- Sep 20, 2017
2015 – 2016
United States locations
- U.S. sites
- 25
- U.S. states
- 10
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Glendale | Arizona | 85308 | — |
| Not listed | Phoenix | Arizona | 85018 | — |
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | Anaheim | California | 92801 | — |
| Not listed | Norco | California | 92860 | — |
| Not listed | Sacramento | California | 95821 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Tustin | California | 92780 | — |
| Not listed | Fort Myers | Florida | 33912 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Orlando | Florida | 32801 | — |
| Not listed | Tampa | Florida | 33634 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Blackfoot | Idaho | 83321 | — |
| Not listed | Boise | Idaho | 83642 | — |
| Not listed | Belleville | Illinois | 62220 | — |
| Not listed | Blue Island | Illinois | 60406 | — |
| Not listed | Chicago | Illinois | 60616 | — |
| Not listed | Hazelwood | Missouri | 63042 | — |
| Not listed | Cleveland | Ohio | 44122 | — |
| Not listed | Spartanburg | South Carolina | 29303 | — |
| Not listed | Knoxville | Tennessee | 37909 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78218 | — |
| Not listed | San Antonio | Texas | 78228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02643251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2017 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.